InMed Pharmaceuticals Inc.
INM | NASDAQ
$13.21
-$4.29 (-24.53%)
At close: Nov 5, 2026, 4:00 PM ET
$13.53
+$0.32 (+2.42%)
After-hours:
Nov 5, 2026, 4:28 PM ET
Fiscal Quarter Period Ending | Q1 2027 Sep 30, 2026 | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | 2.06B | n/a | 1.13M | 1.12M | 1.78M | 1.26M | 1.11M | 1.26M | 1.28M | 1.17M | 1.24M | 901.86K | 3.06M | 1.03M | 636.06K | 443.06K | 514.76K | 309.59K | 335.22K | n/a |
Cost of Revenue | 221.04K | 1.75B | n/a | 1.09M | 716.96K | 991.69K | 1.09M | 650.81K | 771.23K | 817K | 883.14K | 916.06K | 880.62K | 981.21K | 984.04K | 458.47K | 1.12M | 409.57K | 270.1K | 194.15K | n/a |
Gross Profit | -221.04K | 306.94M | n/a | 35.92K | 403.16K | 785.47K | 175.63K | 460.89K | 493.41K | 466.07K | 289.46K | 324.14K | 21.24K | 2.08M | 49.89K | 177.59K | -678.17K | 105.19K | 39.49K | 141.06K | n/a |
Operating Income | -2.01M | -3.21M | -2.82M | -2.91M | -1.76M | -2.44M | -2.12M | -2.21M | -1.75M | -2.01M | -1.8M | -1.7M | n/a | -613.08K | -2.15M | -2.96M | -4.74M | -3.05M | -3.54M | -5.39M | -2.89M |
Interest Income | 14.31K | 1.38K | 47.77K | 102.06K | 93.77K | 51.69K | 16.64K | 30.54K | 56.83K | 141.74K | 164.82K | 221.04K | 184.23K | 196.81K | 210.31K | 155.59K | 99.5K | 43.39K | 38.69K | 33.49K | 6.52K |
Pretax Income | -2M | -4.84M | -2.79M | -2.78M | -1.73M | -2.44M | -2.12M | -2.58M | -1.68M | -1.93M | -1.72M | -1.48M | -2.54M | -445.89K | -2M | -2.84M | -4.84M | -7.87M | -3.48M | -5.42M | -2.97M |
Net Income | -2.33M | -5.08M | -2.97M | -2.78M | -1.73M | -2.44M | -2.12M | -2.58M | -1.68M | -1.94M | -1.72M | -1.48M | -2.54M | -448.28K | -2M | -2.84M | -4.85M | -7.87M | -3.48M | -5.42M | -2.97M |
Selling & General & Admin | 1.8B | 1.87B | 1.74M | 2.08M | 1.53M | 3.07M | 1.33M | 1.55M | 1.42M | 1.21M | 1.37M | 1.36M | 1.3M | 1.87M | 1.32M | 1.98M | 2.16M | 1.65M | 1.83M | 2.32M | 1.37M |
Research & Development | 206.02M | 567.89M | 1.02M | 865.31K | 581.61K | 153.54K | 909.65K | 1.06M | 771.18K | 1.21M | 656.76K | 609.79K | 1.29M | 826.29K | 878.3K | 1.15M | 1.9M | 1.5M | 1.75M | 3.21M | 1.49M |
Other Expenses | -2.01B | -2.44B | 51.71K | n/a | 53.2K | n/a | 52.31K | 53.2K | 54.58K | 54.77K | 54.77K | 55.23K | -2.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 28.53K |
Operating Expenses | 1.79M | 2.95M | 2.82M | 2.95M | 2.17M | 3.22M | 2.29M | 2.67M | 2.25M | 2.48M | 2.09M | 2.03M | 21.24K | 2.69M | 2.2M | 3.14M | 4.06M | 3.15M | 3.58M | 5.53M | 2.89M |
Interest Expense | n/a | 10.7K | n/a | n/a | n/a | 20K | n/a | 351.55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.01M | 3.21M | 2.82M | 4.04M | 2.88M | 4.21M | 3.38M | 3.32M | 3.02M | 3.29M | 2.97M | 2.95M | 901.86K | 3.67M | 3.18M | 3.59M | 5.18M | 3.56M | 3.85M | 5.73M | 2.89M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.1K | n/a | n/a | n/a | 2.38K | 1.5K | 4.06K | 9.39K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 5.47M | 4.37M | 4.05M | 3.95M | 3.95M | 2M | 1.1M | 706.55K | 620.13K | 445.95K | 480.65K | 398.67K | 166.41K | 166.41K | 166.41K | 115.03K | 43.28K | 35.79K | 28.3K | 27.69K | 24.1K |
Shares Outstanding (Diluted) | 5.47M | 4.37M | 4.05M | 3.95M | 3.95M | 2M | 1.1M | 706.55K | 620.13K | 445.95K | 480.65K | 398.67K | 166.41K | 166.41K | 166.41K | 115.03K | 43.28K | 35.79K | 28.3K | 27.69K | 24.1K |
EPS (Basic) | -0.43 | -1.43 | -0.73 | -0.71 | -0.61 | -1.22 | -1.94 | -3.64 | -2.71 | -4.35 | -3.58 | -3.71 | -15.24 | -2.69 | -12.01 | -24.73 | -112.02 | -219.88 | -122.80 | -195.56 | -123.33 |
EPS (Diluted) | -0.43 | -1.43 | -0.73 | -0.71 | -0.61 | -1.22 | -1.94 | -3.64 | -2.71 | -4.35 | -3.58 | -3.71 | -15.24 | -2.69 | -12.01 | -24.73 | -112.02 | -219.88 | -122.80 | -195.56 | -123.33 |
EBITDA | -1.79M | -2.95M | -2.66M | -2.62M | -1.57M | -2.38M | -1.99M | -2.09M | -1.53M | -1.78M | -1.57M | -1.33M | -2.48M | -532.94K | -1.85M | -2.88M | -4.66M | -7.73M | -3.33M | -5.31M | -2.92M |
EBIT | -2.01M | -3.21M | -2.79M | -2.78M | -1.73M | -2.51M | -2.12M | -2.22M | -1.68M | -1.93M | -1.72M | -1.48M | -2.62M | -683.91K | -2M | -3.02M | -4.81M | -7.87M | -3.48M | -5.45M | -2.97M |
Depreciation & Amortization | 221.04K | 260.2K | 133.46K | 158.02K | 156.68K | 131.08K | 129.58K | 129.08K | 144.98K | 151.86K | 150.69K | 152.61K | 149.36K | 150.97K | 142.62K | 147.36K | 148.51K | 144.52K | 142.79K | 138.06K | 54.44K |
Add to Watchlist
Select watchlists to add or remove INM